GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma

MLA

Zhiqing Fang, et al. “GABPA-Activated TGFBR2 Transcription Inhibits Aggressiveness but Is Epigenetically Erased by Oncometabolites in Renal Cell Carcinoma.” Journal of Experimental & Clinical Cancer Research, vol. 41, no. 1, May 2022, pp. 1–20. EBSCOhost, https://doi.org/10.1186/s13046-022-02382-6.

APA

Zhiqing Fang, Ning Zhang, Xiaotian Yuan, Xiangling Xing, Xiaofeng Li, Xin Qin, Zhengfang Liu, Shiyong Neo, Cheng Liu, Feng Kong, Magnus Björkholm, Yidong Fan, & Dawei Xu. (2022). GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma. Journal of Experimental & Clinical Cancer Research, 41(1), 1–20. https://doi.org/10.1186/s13046-022-02382-6

Chicago

Zhiqing Fang, Ning Zhang, Xiaotian Yuan, Xiangling Xing, Xiaofeng Li, Xin Qin, Zhengfang Liu, et al. 2022. “GABPA-Activated TGFBR2 Transcription Inhibits Aggressiveness but Is Epigenetically Erased by Oncometabolites in Renal Cell Carcinoma.” Journal of Experimental & Clinical Cancer Research 41 (1): 1–20. doi:10.1186/s13046-022-02382-6.